Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Unlu, C. Mason, M. Schachter, A. Hughes (2000)
Perillyl alcohol, an inhibitor of geranylgeranyl transferase, induces apoptosis of immortalized human vascular smooth muscle cells in vitro.Journal of cardiovascular pharmacology, 35 2
G. Wang, Sho‐Ya Wang (1994)
Binding of benzocaine in batrachotoxin-modified Na+ channels. State- dependent interactionsThe Journal of General Physiology, 103
J. López-Barneo, T. Hoshi, S. Heinemann, R. Aldrich (1993)
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels.Receptors & channels, 1 1
C. Valenzuela, E. Delpón, L. Franqueza, Pilar Gay, D. Snyders, J. Tamargo (1997)
Effects of Ropivacaine on a Potassium Channel (hKv1.5) Cloned from Human VentricleAnesthesiology, 86
Dirk Snyders, M. Tamkun, Paul Bennett (1993)
A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expressionThe Journal of General Physiology, 101
T. Hoshi, W. Zagotta, R. Aldrich (1990)
Biophysical and molecular mechanisms of Shaker potassium channel inactivationScience, 250
B. Hille (1977)
Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reactionThe Journal of General Physiology, 69
Fred Chen, David Steele, D. Fedida (1997)
Allosteric Effects of Permeating Cations on Gating Currents during K+ Channel DeactivationThe Journal of General Physiology, 110
T. Baukrowitz, G. Yellen (1995)
Modulation of K+ current by frequency and external [K+]: A tale of two inactivation mechanismsNeuron, 15
G. Tseng, B. Zhu, S. Ling, J. Yao (1996)
Quinidine enhances and suppresses Kv1.2 from outside and inside the cell, respectively.The Journal of pharmacology and experimental therapeutics, 279 2
S. Yeola, T. Rich, V. Uebele, M. Tamkun, D. Snyders (1996)
Molecular analysis of a binding site for quinidine in a human cardiac delayed rectifier K+ channel. Role of S6 in antiarrhythmic drug binding.Circulation research, 78 6
Kathleen Choi, R. Aldrich, G. Yellen, G. Yellen (1991)
Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.Proceedings of the National Academy of Sciences of the United States of America, 88
T. Baukrowitz, G. Yellen (1996)
Two functionally distinct subsites for the binding of internal blockers to the pore of voltage-activated K+ channels.Proceedings of the National Academy of Sciences of the United States of America, 93 23
Richard Harris, H. Larsson, E. Isacoff (1998)
A permanent ion binding site located between two gates of the Shaker K+ channel.Biophysical journal, 74 4
E. Delpón, C. Valenzuela, P. Gay, L. Franqueza, D. Snyders, J. Tamargo (1997)
Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.Cardiovascular research, 35 2
E. Carmeliet (1993)
Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes.Circulation research, 73 5
Carmen Valenzuela, E. Delpón, M. Tamkun, J. Tamargo, D. Snyders (1995)
Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.Biophysical journal, 69 2
T. Rich, D. Snyders (1998)
Evidence for multiple open and inactivated states of the hKv1.5 delayed rectifier.Biophysical journal, 75 1
C. Armstrong (1971)
Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant AxonsThe Journal of General Physiology, 58
M. Longobardo, E. Delpón, R. Caballero, Juan Tamargo, Carmen Valenzuela (1998)
Structural determinants of potency and stereoselective block of hKv1.5 channels induced by local anesthetics.Molecular pharmacology, 54 1
X. Zhang, J. Anderson, D. Fedida (1997)
Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5.The Journal of pharmacology and experimental therapeutics, 281 3
Zhiguo Wang, B. Fermini, S. Nattel (1993)
Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circulation research, 73 6
L. Kiss, S. Korn (1998)
Modulation of C-type inactivation by K+ at the potassium channel selectivity filter.Biophysical journal, 74 4
L. Franqueza, M. Longobardo, J. Vicente, E. Delpón, M. Tamkun, J. Tamargo, D. Snyders, C. Valenzuela (1997)
Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels.Circulation research, 81 6
Dirk Snyders, Sarita Yeola (1995)
Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.Circulation research, 77 3
R. Rasmusson, M. Morales, S. Wang, S. Liu, D. Campbell, M. Brahmajothi, H. Strauss (1998)
Inactivation of voltage-gated cardiac K+ channels.Circulation research, 82 7
AbstractObjective: The aim of this study was to analyze the effects of a neutral local anaesthetic, benzocaine, on a cardiac K+ channel cloned from human ventricle. Methods: Experiments were performed on hKv1.5 channels stably expressed on mouse cells using the whole-cell configuration of the patch clamp technique. Results: At 10 nM, benzocaine increased the current amplitude (“agonist effect”) by shifting the activation curve 8.4±2.7 mV in the negative direction, and slowed the time course of tail current decline. In contrast, benzocaine (100–700 μM) inhibited hKv1.5 currents (KD=901±81 μM), modified the voltage-dependence of channel activation, which became biphasic, and accelerated the channel deactivation. Extracellular K+ concentration ([K+]o) also affected the channel gating. At 140 mM [K+]o, the time course of tail currents deactivation was significantly accelerated, whereas at 0 mM [K+]o, it was slowed. At both [K+]o the activation curve became biphasic. Benzocaine accelerated the tail current decay at 0 mM but not at 140 mM [K+]o. The reduction in the permeation of K+ through the pore did not modify the blocking effects of micromolar concentrations of benzocaine, but suppressed the agonist effect observed at nanomolar concentrations. Conclusions: All these results suggest that benzocaine blocks and modifies the voltage- and time-dependent properties of hKv1.5 channels, binding to an extracellular and to an intracellular site at the channel level. Moreover, both sites are related to each other and can also interact with K+.
Cardiovascular Research – Oxford University Press
Published: May 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.